臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

关于TAIR
	计画说明

浏览
	典藏机构
	作者
	题名
	日期
	统计图表
	机构即时统计
	学术趋势

消息
	2019臺灣學術機構典藏研討會
	機構典藏系統RC7版本已發佈

著作权
	出版社及期刊政策查询
	TAIR著作权会议记录

相关连结
	機構典藏計畫網站
	ROAR
	OpenDOAR
	SHERPA
	OAIster
	JAIRO
	Ira
	DSPACE
	RWWR
	臺大學術典藏NTU Scholars

"chiun hsu"的相关文件

回到依作者浏览
依题名排序	依日期排序

显示项目 26-50 / 356 (共15页)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
每页显示[10|25|50]项目

机构	日期	题名	作者
臺大學術典藏	2022-08-19T00:21:09Z	Multifractionated paclitaxel and cisplatin combined with 5-fluorouracil and leucovorin in patients with metastatic or recurrent esophageal squamous cell carcinoma	Lin C.-C.; Yeh K.-H.; Yang C.-H.; CHIUN HSU; Tsai Y.-C.; Hsu W.-L.; Cheng A.-L.; Hsu C.-H.
臺大學術典藏	2022-08-19T00:21:08Z	Predictors of toxicity of weekly docetaxel in chemotherapy-treated non-small cell lung cancers	Chen J.-P.; Lo Y.; Yu C.-J.; CHIUN HSU; Shih J.-Y.; Yang C.-H.
臺大學術典藏	2022-08-19T00:21:08Z	A revisit of prophylactic lamivudine for chemotherapy-associated hepatitis B reactivation in non-Hodgkin's lymphoma: A randomized trial	Cheng A.-L.; Chen P.-J.; Wu H.-B.; Tien H.-F.; Chao T.-Y.; Liu T.-W.; Li C.-C.; Liao Y.-M.; Chang M.-C.; Young J.-H.; Hsiao H.-H.; Lin T.-H.; Lin S.-F.; Wang M.-C.; Hwang W.-S.; Su I.-J.; CHIUN HSU; Hsiung C.A.
臺大學術典藏	2022-08-19T00:21:08Z	Outcome of advanced nonsmall cell lung cancer patients receiving gemcitabine and weekly paclitaxel as first-line treatment	Lin Z.-Z.; CHIUN HSU; Chang Y.-C.; Yu C.-J.; Hsu C.-H.; Lin C.-C.; Cheng A.-L.; Yang P.-C.; Yang C.-H.
臺大學術典藏	2022-08-19T00:21:07Z	Gemcitabine plus conventional-dose epirubicin versus gemcitabine plus cisplatin as first-line chemotherapy for stage IIIB/IV non-small cell lung carcinoma-A randomized phase II trial	CHIUN HSU; Kuo S.-H.; Hu F.-C.; Cheng A.-L.; Shih J.-Y.; Yu C.-J.; Lin C.-C.; Huang T.-C.; Yang P.-C.; Yang C.-H.
臺大學術典藏	2022-08-19T00:21:07Z	Serum vascular endothelial growth factor/soluble vascular endothelial growth factor receptor 1 ratio is an independent prognostic marker in pancreatic cancer	Chang Y.-T.; Chang M.-C.; Wei S.-C.; Tien Y.-W.; CHIUN HSU; Liang P.-C.; Tsao P.-N.; Jan I.-S.; Wong J.-M.
臺大學術典藏	2022-08-19T00:21:07Z	Weekly cisplatin, infusional high-dose 5-fluorouracil and leucovorin for advanced, recurrent and metastatic cervical carcinoma	Hsiao S.-M.; Chen C.-A.; CHIUN HSU; Lin H.-H.; Hsieh C.-Y.; Wei L.-H.
臺大學術典藏	2022-08-19T00:21:06Z	Nuclear overexpression of mitotic regulatory proteins in biliary tract cancer: Correlation with clinicopathologic features and patient survival	Shen Y.-C.; Hu F.-C.; Jeng Y.-M.; Chang Y.-T.; Lin Z.-Z.; Chang M.-C.; CHIUN HSU; Cheng A.-L.
臺大學術典藏	2022-08-19T00:21:05Z	Bortezomib overcomes tumor necrosis factor-related apoptosis-inducing ligand resistance in hepatocellular carcinoma cells in part through the inhibition of the phosphatidylinositol 3-kinase/Akt pathway	Chen K.-F.; Yeh P.-Y.; CHIUN HSU; Hsu C.-H.; Lu Y.-S.; Hsieh H.-P.; Chen P.-J.; Cheng A.-L.
臺大學術典藏	2022-08-19T00:21:05Z	Induction of Bim expression contributes to the antitumor synergy between sorafenib and mitogen-activated protein kinase/extracellular signal-regulated kinase kinase inhibitor CI-1040 in hepatocellular carcinoma	Cheng A.-L.; CHIUN HSU; Wang D.-S.; Lu Y.-S.; Fan H.-H.; Ou D.-L.; Shen Y.-C.; Liang J.-D.; Liou J.-Y.; Yu S.-L.
臺大學術典藏	2022-08-19T00:21:04Z	Bortezomib suppresses focal adhesion kinase expression via interrupting nuclear factor-kappa B	Liou J.-Y.; Shyue S.-K.; Chang C.-C.; Golubovskaya V.M.; Shen T.-L.; Shen Y.-C.; CHIUN HSU; Kuo C.-C.; Ko B.-S.; Chang T.-C.; Chen C.-H.; Liu C.-C.
臺大學術典藏	2022-08-19T00:21:04Z	Geographic difference in survival outcome for advanced hepatocellular carcinoma: Implications on future clinical trial design	CHIUN HSU; Shen Y.-C.; Cheng C.-C.; Hu F.-C.; Cheng A.-L.
臺大學術典藏	2022-08-19T00:21:04Z	Overexpressed focal adhesion kinase predicts a higher incidence of extrahepatic metastasis and worse survival in hepatocellular carcinoma	Jan Y.-J.; Ko B.-S.; CHIUN HSU; Chang T.-C.; Chen S.-C.; Wang J.; Liou J.-Y.
臺大學術典藏	2022-08-19T00:21:04Z	Sorafenib for the treatment of hepatocellular carcinoma across geographic regions	CHIUN HSU; Shen Y.-C.; Cheng A.L.
臺大學術典藏	2022-08-19T00:21:03Z	Issues and controversies of hepatocellular carcinoma-targeted therapy clinical trials in Asia: Experts'opinion	Chen P.-J.; Furuse J.; Han K.-H.; CHIUN HSU; Lim H.-Y.; Moon H.; Qin S.; Ye S.-L.; Yeoh E.-M.; Yeo W.
臺大學術典藏	2022-08-19T00:21:03Z	Phase II study of combining sorafenib with metronomic tegafur/uracil for advanced hepatocellular carcinoma	Cheng A.-L.; Ding Y.-H.; CHIUN HSU; Shao Y.-Y.; Chen P.-J.; Lin Z.-Z.; Shen Y.-C.; Hsu C.-H.
臺大學術典藏	2022-08-19T00:21:02Z	Clinical Development and Future Direction for the Treatment of Hepatocellular Carcinoma	Whang-Peng J.; Cheng A.-L.; CHIUN HSU; Chen C.-M.
臺大學術典藏	2022-08-19T00:21:02Z	Predictive and prognostic values of tau and ERCC1 in advanced breast cancer patients treated with paclitaxel and cisplatin	Cheng A.-L.; Lin C.-H.; Chang K.-J.; Kuo W.-H.; CHIUN HSU; Lee W.-C.; Liau J.-Y.; Huang C.-S.; Lu Y.-S.; Shao Y.-Y.; Kuo K.-T.; Hu F.-C.
臺大學術典藏	2022-08-19T00:21:01Z	Early alpha-fetoprotein response predicts treatment efficacy of antiangiogenic systemic therapy in patients with advanced hepatocellular carcinoma	Cheng A.-L.; Hsu C.-H.; Shen Y.-C.; CHIUN HSU; Lin Z.-Z.; Shao Y.-Y.
臺大學術典藏	2022-08-19T00:21:00Z	Overexpression of 14-3-3�` predicts tumour metastasis and poor survival in hepatocellular carcinoma	Liou J.-Y.; Ko B.-S.; Chang T.-C.; CHIUN HSU; Chen Y.-C.; Shen T.-L.; Chen S.-C.; Wang J.; Wu K.K.; Jan Y.-J.
臺大學術典藏	2022-08-19T00:21:00Z	Dynamic contrast-enhanced magnetic resonance imaging biomarkers predict survival and response in hepatocellular carcinoma patients treated with sorafenib and metronomic tegafur/uracil	Wei S.-Y.; Cheng A.-L.; Shih T.T.-F.; Chen B.-B.; Hsu C.-H.; Hu F.-C.; CHIUN HSU; Yu C.-W.; Shen Y.-C.; Hsu C.-Y.
臺大學術典藏	2022-08-19T00:20:59Z	Increased expression of 14-3-3�] promotes tumor progression and predicts extrahepatic metastasis and worse survival in hepatocellular carcinoma	Shen T.-L.; Lee Y.-M.; Chen P.-F.; Wang J.; Shyue S.-K.; Liou J.-Y.; CHIUN HSU; Liang S.-M.; Hung Y.-L.; Chen S.-C.; Jan Y.-J.; Ko B.-S.; Liu T.-A.
臺大學術典藏	2022-08-19T00:20:59Z	Lack of efficacy to systemic chemotherapy for treatment of metaplastic carcinoma of the breast in the modern era	Lu Y.S.; Cheng A.L.; Kuo W.H.; Chen I.C.; Lin C.H.; Huang C.S.; Lien H.C.; CHIUN HSU
臺大學術典藏	2022-08-19T00:20:58Z	Efficacy, safety, and potential biomarkers of thalidomide plus metronomic chemotherapy for advanced hepatocellular carcinoma	Shao Y.-Y.; Lin Z.-Z.; CHIUN HSU; Lee K.-D.; Hsiao C.-H.; Lu Y.-S.; Huang C.-C.; Shen Y.-C.; Hsu C.-H.; Cheng A.-L.
臺大學術典藏	2022-08-19T00:20:58Z	Antiangiogenic strategies for the treatment of hepatocellular carcinoma	CHIUN HSU; Shen Y.-C.; Cheng A.-L.

显示项目 26-50 / 356 (共15页)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
每页显示[10|25|50]项目

	English \| 正體中文 \| 简体中文 \| 总笔数 :0
	造访人次 : 52816424 在线人数 : 615 教育部委托研究计画计画执行:国立台湾大学图书馆